MedPage Today) — A randomized trial laid the groundwork for FFRangio, a proprietary angiography-derived fractional flow reserve (FFR) tool, as a potential gatekeeper for coronary revascularization.
When put to the test in the PROVISION trial…
FFRangio Makes a Strong Impression as Wannabe FFR Alternative

Leave a Comment Leave a Comment